Crescent Biopharma (CBIO) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.92% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -53.84% |
| Jun 30, 2023 | -49.59% |
| Mar 31, 2023 | -42.65% |
| Dec 31, 2022 | -34.28% |
| Sep 30, 2022 | -32.69% |
| Jun 30, 2022 | -32.20% |
| Mar 31, 2022 | -36.75% |
| Dec 31, 2021 | -40.57% |
| Sep 30, 2021 | -35.30% |
| Jun 30, 2021 | -30.65% |
| Mar 31, 2021 | -27.45% |
| Dec 31, 2020 | -24.58% |
| Sep 30, 2020 | -24.69% |
| Jun 30, 2020 | -23.85% |
| Mar 31, 2020 | -20.72% |
| Dec 31, 2019 | -14.03% |
| Sep 30, 2019 | -9.31% |
| Jun 30, 2019 | -7.97% |
| Mar 31, 2019 | -8.77% |
| Dec 31, 2018 | -13.52% |
| Sep 30, 2018 | -13.69% |
| Jun 30, 2018 | -12.86% |
| Mar 31, 2018 | -1.84% |
| Dec 31, 2017 | 4.79% |
| Sep 30, 2017 | 65.86% |
| Jun 30, 2017 | 137.63% |
| Mar 31, 2017 | 118.66% |
| Dec 31, 2016 | 102.60% |
| Sep 30, 2016 | 19.28% |
| Jun 30, 2016 | -15.74% |
| Mar 31, 2016 | 16.90% |
| Dec 31, 2015 | 15.28% |
| Sep 30, 2015 | 17.72% |
| Jun 30, 2015 | 37.69% |
| Mar 31, 2015 | 10.89% |
| Dec 31, 2014 | 13.12% |